Rod Wong
Chairman at ROCKET PHARMACEUTICALS, INC.
Net worth: 39 M $ as of 2024-04-29
Profile
Dr. Roderick T.
Wong is a Chairman at Rocket Pharmaceuticals, Inc., a Managing Partner & Chief Investment Officer at RTW Investments LP and a Managing Partner & Chief Investment Officer at RTW Investments /Venture/.
He is on the Board of Directors at NiKang Therapeutics, Inc. and Attune Pharmaceuticals, Inc. In addition to his leadership of the firm, he manages the firm’s investments focused on innovative drug development.
Dr. Wong was previously employed as a Chairman, President & Chief Executive Officer by Health Sciences Acquisitions Corp.
2, an Independent Director by Avidity Biosciences, Inc., an Independent Director by Landos Biopharma, Inc., a Chairman, President & Chief Executive Officer by Health Sciences Acquisitions Corp., and a Principal by Davidson Kempner Capital Management LLC.
He also served on the board at Penwest Pharmaceuticals Co. and Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
He received his undergraduate degree from Duke University, an MBA from Harvard Business School and a doctorate degree from Perelman School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-12 | 29,693,872 ( 7.71% ) | 39 M $ | 2024-04-29 | |
| 2023-06-21 | 0 ( -.--% ) | - $ | 2024-04-29 |
Rod Wong active positions
| Companies | Position | Start |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Chairman | 2017-12-31 |
RTW Investments LP
 RTW Investments LP Investment ManagersFinance RTW Investments LP (RTW) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Roderick Wong in 2010. RTW provides discretionary advisory services to various RTW Funds. | Chief Executive Officer | 2010-01-31 |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Director/Board Member | 2018-05-31 |
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Chief Investment Officer | - |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Director/Board Member | 2020-08-31 |
Former positions of Rod Wong
| Companies | Position | End |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Director/Board Member | 2022-06-06 |
| AVIDITY BIOSCIENCES, INC. | Director/Board Member | 2021-08-24 |
| IMMUNOVANT, INC. | Chief Executive Officer | 2019-11-30 |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Chairman | 2017-12-31 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Rod Wong
| Duke University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
| Perelman School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| Private companies | 9 |
|---|---|
Davidson Kempner Capital Management LP
 Davidson Kempner Capital Management LP Investment ManagersFinance Davidson Kempner Capital Management LLC (DKCM) is an independent, SEC-registered investment advisor and hedge fund management firm headquartered in New York City. The firm was founded in 1983 by Marvin Davidson and Thomas Kempner Sr. DKCM provides investment advice and investment management services to private investment funds. | Finance |
RTW Investments LP
RTW Investments LP Investment ManagersFinance RTW Investments LP (RTW) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Roderick Wong in 2010. RTW provides discretionary advisory services to various RTW Funds. | Finance |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Commercial Services |
Health Sciences Acquisitions Corp.
 Health Sciences Acquisitions Corp. Financial ConglomeratesFinance Health Sciences Acquisitions Corp. operates as a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It pursues prospective targets that are focused on healthcare innovation domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors. The company was founded on December 06, 2018 and is headquartered in New York, NY. | Finance |
RTW Investments /Venture/
RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Finance |
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Health Technology |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
 Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. is a Chinese company that develops and commercializes novel therapeutics. Yan Ping Mou has been the CEO of the company since 2023. | Health Technology |
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Rod Wong
